Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.

Peter NashPascal RichetteLaure GossecAntonio MarchesoniChristopher RitchlinKoji KatoErin L McDearmon-BlondellElizabeth LesserReva McCaskillDai FengJaclyn K AndersonEric M Ruderman

Published in: Rheumatology (Oxford, England) (2021)

ClinicalTrials.gov, https://clinicaltrials.gov, SELECT-PsA 1 (NCT03104400); SELECT-PsA 2 (NCT03104374).

Keyphrases

prostate cancer
rheumatoid arthritis
radical prostatectomy
combination therapy
disease activity
rheumatoid arthritis patients
open label